Topic: Pharmaceuticals

Compassionate Leadership in Labour Disputes: The Case of Dr Reddy’s Laboratories

The employment terms of contract workers led to a 100-day long dispute between Dr Reddy’s Laboratories management and a trade union. Dr Reddy’s Laboratories (DRL) Labour Dispute case study author Professor Subramaniam Ramnarayan provides insights on multi-stakeholder negotiations and resolving conflict through compassionate leadership. ISBInsight: How did this case catch your attention? Subramaniam Ramnarayan: The Confederation of Indian Industry (CII) had organised …

Read More »

FMCG Lessons for Pharma

 By Meenakshee Sinha and S. Arunachalam What were the key success factors for Arogya Parivar, a bottom-of-the-pyramid initiative by Swiss pharmaceutical major Novartis? In this article, Meenakshee Sinha and Professor S. Arunachalam present a replicable fast-moving consumer good blueprint for rural marketing based on the Arogya Parivar experience. The Transforming Pharma Landscape In the past century, scientific breakthroughs and economic development enabled pharmaceutical …

Read More »

The Side Effects of Drug Price Controls

Based on the research of Chirantan Chatterjee, Ajay Bhaskarabhatla, Enrico Pennings and Anurag Priyatam. The 2013 Drug Price Control Order capped prices of over 300 drugs in the Indian market. Using an experimental design to assess the consequences of this price control on the anti-diabetic drug Metformin, Professor Chirantan Chatterjee and his co-authors show the unintended consequences of such price regulation. Price controls …

Read More »

Big Data in Health Care: Analytics to Action

In this paper, the author discusses how big data and analytics in health care are now available at different organisational levels like providers, hospitals and pharmaceuticals and how these data can deliver insights that can be translated into actions for improving delivery, reducing cost of care and enhancing transparency. Big data is changing the way business decisions are being made around …

Read More »

Organic and Inorganic Internationalisation: Insights From Dr Reddy’s Labs

Dr Reddy’s Laboratories (DRL) was promoted in 1984 by Anji Reddy, a pioneering scientist-entrepreneur, as a manufacturer of bulk drugs or active pharmaceutical ingredients (APIs). Over the last three decades, DRL has emerged as an integrated global pharmaceutical company offering a wide range of products including APIs, generics, biosimilars,  and differentiated  formulations.  Nearly 80% of the company’s revenues  are derived …

Read More »

Novartis in India: Innovation versus Affordability

Professor Anand Nandkumar of ISB, Professor Charles Dhanaraj of Kelley School of Business, along with Mridula Anand, trace Novartis’ prolonged tussle with the Indian patent regime to get its cancer drug, Glivec, patented in India. The case is set against the backdrop of the Intellectual Property Appellate Board declining Novartis’ patent application on the grounds that the cost of the …

Read More »

Merck: A Family Success Story

Ajay Bhalla, Professor of Global Innovation Management at Cass Business School in London and Associate Faculty, Thomas Schmidheiny Chair of Family Business and Wealth Management, Indian School of Business (ISB) talks with Dr Frank Stangenberg–Haverkamp, Chairman, Board of Partners, E Merck KG, Germany on challenges that family businesses face in sustaining the family and business as two separate institutions and …

Read More »
Scroll To Top